New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 27, 2017 – Teva launched an AB-rated generic version of Galderma’s Epiduo (adapalene/benzoyl peroxide) 0.1%/2.5% gel for the topical treatment of acne vulgaris in patients 9 years of age and older.
Download PDF
Return to publications
